- Home
- WES vs NBIX Comparison
WES vs NBIX Comparison
Compare WES & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WES
- NBIX
- Stock Information
- Founded
- WES 2007
- NBIX 1992
- Country
- WES United States
- NBIX United States
- Employees
- WES N/A
- NBIX N/A
- Industry
- WES Natural Gas Distribution
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WES Utilities
- NBIX Health Care
- Exchange
- WES Nasdaq
- NBIX Nasdaq
- Market Cap
- WES 15.0B
- NBIX 14.4B
- IPO Year
- WES 2008
- NBIX 1996
- Fundamental
- Price
- WES $39.39
- NBIX $149.46
- Analyst Decision
- WES Hold
- NBIX Strong Buy
- Analyst Count
- WES 5
- NBIX 18
- Target Price
- WES $40.00
- NBIX $172.06
- AVG Volume (30 Days)
- WES 1.8M
- NBIX 1.1M
- Earning Date
- WES 11-04-2025
- NBIX 10-28-2025
- Dividend Yield
- WES 9.30%
- NBIX N/A
- EPS Growth
- WES N/A
- NBIX 12.44
- EPS
- WES 3.38
- NBIX 4.19
- Revenue
- WES $3,740,425,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- WES $7.07
- NBIX $23.68
- Revenue Next Year
- WES $7.20
- NBIX $18.02
- P/E Ratio
- WES $11.58
- NBIX $35.79
- Revenue Growth
- WES 5.81
- NBIX 19.61
- 52 Week Low
- WES $33.60
- NBIX $84.23
- 52 Week High
- WES $43.33
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- WES 59.83
- NBIX 58.02
- Support Level
- WES $37.75
- NBIX $133.62
- Resistance Level
- WES $38.92
- NBIX $157.67
- Average True Range (ATR)
- WES 0.77
- NBIX 5.06
- MACD
- WES 0.14
- NBIX 0.91
- Stochastic Oscillator
- WES 98.65
- NBIX 65.74
About WES Western Midstream Partners LP Common Units Representing Limited Partner Interests
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.